S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells

Metastatic melanoma is one of the most aggressive and drug-resistant cancers with very poor overall survival. Circulating melanoma cells (CMCs) were first described in 1991. However, there is no general consensus on the clinical utility of CMC detection, largely due to conflicting results linked to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cayrefourcq, Laure, De Roeck, Aurélie, Garcia, Caroline, Stoebner, Pierre-Emmanuel, Fichel, Fanny, Garima, Françoise, Perriard, Françoise, Daures, Jean-Pierre, Meunier, Laurent, Alix-Panabières, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678250/
https://www.ncbi.nlm.nih.gov/pubmed/31330795
http://dx.doi.org/10.3390/cells8070755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678250/
https://www.ncbi.nlm.nih.gov/pubmed/31330795
http://dx.doi.org/10.3390/cells8070755

Ejemplares similares